GNH USA

Europe — EMA

Monoket Retard (Isosorbide Mononitrate)

GNH USA supplies Monoket Retard (Isosorbide Mononitrate), a nitrate vasodilator for chronic stable angina, heart failure and hypertension.

Request sourcing

1
Pack/s

What is Isosorbide Mononitrate?

Isosorbide mononitrate, the active ingredient in Monoket Retard, is a nitrate vasodilator presented as an oral tablet for oral use. It is employed to prevent episodes of angina and to manage hypertension in adults with chronic stable angina, heart failure, or elevated blood pressure.

GNH USA supplies Monoket Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Isosorbide Mononitrate used for?

Monoket Retard is indicated for several cardiovascular conditions where nitrate‑mediated vasodilation improves myocardial oxygen balance.

- Chronic stable angina pectoris: reduces frequency of angina attacks by lowering cardiac workload. - Heart failure: improves symptoms by decreasing preload and afterload. - Hypertension: contributes to blood‑pressure reduction through arterial dilation.

What are the side effects of Isosorbide Mononitrate?

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: throbbing or pressure‑type pain. - Dizziness or light‑headedness: often related to blood‑pressure fall. - Flushing: warm sensation with reddening of skin. - Nausea: mild gastrointestinal upset. - Palpitations: awareness of heartbeat. - Hypotension: mild drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked blood‑pressure reduction requiring medical attention. - Syncope: transient loss of consciousness. - Myocardial infarction: rare but reported in susceptible patients. - Allergic reactions: rash, itching, or swelling. - Methemoglobinemia: rare blood‑disorder causing cyanosis.

What precautions apply to Isosorbide Mononitrate?

Before initiating therapy, clinicians should evaluate cardiovascular status and concomitant medications.

- Blood pressure assessment: ensure baseline values are stable. - Avoid concurrent nitrates: combined use can cause profound hypotension. - Do not combine with phosphodiesterase‑5 inhibitors: risk of severe blood‑pressure fall. - Monitor hepatic function: dose adjustment may be needed in severe impairment. - Discontinue before major surgery: to reduce intra‑operative hypotension. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Isosorbide Mononitrate interact with?

Isosorbide mononitrate may interact with several drug classes.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe hypotension. - Guanylate cyclase stimulators (e.g., riociguat): excessive vasodilation. - Methylene blue: reduces conversion to nitric oxide.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers): may enhance blood‑pressure lowering. - Diuretics: additive effect on volume depletion. - Alcohol: can increase dizziness and hypotension. - Antihistamines: may potentiate headache and flushing.

Frequently asked questions

What conditions is Monoket Retard used for?+
Monoket Retard is prescribed to prevent angina attacks, to manage chronic stable angina, to treat heart failure by reducing cardiac workload, and to lower blood pressure in patients with hypertension. It is used in adult patients where nitrate‑mediated vasodilation is appropriate.
How does isosorbide mononitrate work in the body?+
Isosorbide mononitrate is converted in the body to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, causing relaxation of veins and arteries, decreasing preload and afterload, and improving oxygen delivery to the heart while lowering systemic blood pressure.
What is the usual dose of Monoket Retard?+
The specific dose and dosing schedule of Monoket Retard are determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Monoket Retard safe during pregnancy or breastfeeding?+
Safety data for isosorbide mononitrate in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Monoket Retard from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Monoket Retard compare with other anti‑anginal drugs?+
Monoket Retard belongs to the nitrate class, providing sustained nitric‑oxide release, whereas other anti‑anginals such as beta‑blockers or calcium‑channel blockers act through different mechanisms. Nitrates are particularly effective for relieving angina by reducing cardiac preload, while other classes may target heart rate or vascular tone.
What are the storage requirements for Monoket Retard?+
Monoket Retard tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.
How is Monoket Retard administered?+
Monoket Retard is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed, to maintain its extended‑release properties. Dosing times are set by the prescriber, often once daily.
What are the most serious risks associated with Monoket Retard?+
The most serious risks include severe hypotension, syncope, myocardial infarction, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, chest pain, or signs of an allergic response.
Who should not use Monoket Retard?+
Monoket Retard should be avoided in patients with known hypersensitivity to isosorbide mononitrate or other nitrates, those who have taken phosphodiesterase‑5 inhibitors within 24 hours, and individuals with severe anemia or closed‑angle glaucoma. Contra‑indications are determined by the treating physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Mononitrate
Route
Oral Use
Manufacturer
Merus Labs Luxco Ii S.À R.L.
Origin
EU

Related products